From the The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea (Ryu, Jun, H. Kim, Seo, T. Kim); Corneal Dystrophy Research Institute, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea (Jun, Seo, E.K. Kim, T. Kim); Eyereum Eye Clinic, Seoul, South Korea (Kang, Jean); Biomedical Engineering Office, Research and Development, Schwind eye-tech-solutions GmbH & Co. KG, Kleinostheim, Germany (Arba-Mosquera); Saevit Eye Hospital, Goyang-Si, Gyeonggi-Do, South Korea (E.K. Kim).
J Cataract Refract Surg. 2023 Jan 1;49(1):69-75. doi: 10.1097/j.jcrs.0000000000001042.
To analyze the 6-month outcomes of the treatment combination of the monocular bi-aspheric ablation profile (PresbyMAX) and contralateral aspheric monofocal laser in situ keratomileusis (LASIK) ablation profile for correction of myopia and presbyopia.
Yonsei University College of Medicine and Eyereum Eye Clinic, Seoul, South Korea.
Retrospective case series.
This was a retrospective case review of 92 patients (184 eyes) diagnosed with myopia who underwent uneventful simultaneous bi-aspheric ablation in the nondominant eye and aspheric monofocal regular LASIK in the dominant eye to correct myopia and presbyopia between January 2017 and August 2020. Monocular and binocular uncorrected distance visual acuity (UDVA) and near visual acuity (UNVA), and corrected distance visual acuity and near visual acuity were analyzed postoperatively.
At 6 months postoperatively, the mean UDVAs (logMAR) in the dominant and nondominant eyes were 0.01 ± 0.02 and 0.26 ± 0.15, respectively. Furthermore, all treated dominant eyes achieved 20/20 or better monocular UDVA, and 84% achieved 20/16 or better monocular UDVA. In the nondominant treated eyes, 89% achieved 20/50 or better monocular UDVA, 78% achieved 20/40 or better, and 34% achieved 20/32 or better. The binocular cumulative UDVA at 6 months postoperatively was 20/20 or better in all patients. All patients achieved J2 or better in binocular cumulative UNVA, and 83% achieved J1.
Presbyopia correction using the combination of PresbyMAX in the near eye and aspheric monofocal regular LASIK in the distant eye is a safe and effective treatment for presbyopia in patients with myopia.
分析单眼双非球面消融形态(PresbyMAX)与对侧非球面单焦点激光原位角膜磨镶术(LASIK)消融形态联合治疗近视和老视的 6 个月疗效。
韩国首尔延世大学医学院和 Eyereum 眼科诊所。
回顾性病例系列。
这是一项回顾性病例研究,纳入 2017 年 1 月至 2020 年 8 月期间接受无并发症的非主导眼双眼非球面消融联合主导眼非球面单焦点常规 LASIK 手术以矫正近视和老视的 92 例(184 只眼)近视患者。术后分析单眼和双眼未矫正远视力(UDVA)和近视力(UNVA)以及矫正远视力和近视力。
术后 6 个月,主导眼和非主导眼的平均 UDVA(logMAR)分别为 0.01 ± 0.02 和 0.26 ± 0.15。此外,所有治疗的主导眼均达到 20/20 或更好的单眼 UDVA,84%达到 20/16 或更好的单眼 UDVA。在非主导眼治疗眼,89%达到 20/50 或更好的单眼 UDVA,78%达到 20/40 或更好,34%达到 20/32 或更好。术后 6 个月时,所有患者的双眼累积 UDVA 均达到 20/20 或更好。所有患者的双眼累积 UNVA 均达到 J2 或更好,83%达到 J1。
近视患者采用近眼 PresbyMAX 联合远眼非球面单焦点常规 LASIK 矫正老视是一种安全有效的治疗方法。